Skip to main content
RetiSpec logo

RetiSpec

Toronto, Ontario, CanadaSee on the mapFounded 2016

  • Series A

RetiSpec is a medical imaging company developing AI-powered technology to detect neurodegenerative diseases early. Its approach uses hyperspectral imaging of the eye to support disease detection.

Raised
$11.7M
Jul 2024
Series A
Investors
11
Founded
2016
Employees
11–50

reccy insights

Recent highlights

RetiSpec's latest clearly dated financing milestone is its Series A, announced on Jul 26, 2024. The round raised approximately $9.98 million, with iGan Partners identified as lead investor; Eli Lilly and Company and Topcon Healthcare also appear among the associated investors. Earlier milestones include a $250,000 seed round dated Nov 1, 2019 and a $500,000 grant dated Oct 16, 2019. A further grant is listed on Apr 13, 2023, associated with the Centre for Aging + Brain Health Innovation. The company is developing a non-invasive retinal imaging approach intended to detect Alzheimer's-related pathology before symptoms appear, using AI and hyperspectral imaging. The disclosed information therefore points to continued development of its diagnostic technology and funding support, but does not establish clinical deployment, regulatory clearance, commercial sales, or a more recent financing event.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes RetiSpec distinct

  1. 01Focuses on early detection of neurodegenerative diseases.
  2. 02Combines AI with hyperspectral imaging of the eye.
  3. 03Applies retinal imaging to the detection of neurodegenerative disease markers.
  4. 04Aims to support a non-invasive eye examination for early diagnosis.

Technology & products

  • AI-powered medical imaging.
  • Hyperspectral imaging of the eye for neurodegenerative disease detection.

Research roots1

Labs and research groups this company came from or works with.

  • University of MinnesotaMinneapolis, United States · No page yet
    Licence
Academic data: Carter Sciences

Recent updates3

  • Jun 13, 2025Award

    10 Innovators Making Healthcare More Accessible with AI

    worth.com
  • Dec 13, 2024Partnership

    RetiSpec Raises $10M & Partners to Bring Early Alzheimer's Detection Platform to More People

    youtube.com
  • Dec 3, 2024Award

    Digital Health 50: The most promising digital health startups of 2024

    cbinsights.com

Funding

$11.7M disclosed
Latest valuation $2.143M11 investors

Investors8

Also backed by
  • Alzheimer's Drug Discovery
  • iGan Partners
  • Gentex Corporation

About RetiSpec

Leadership
Eliav ShakedRoy Kirshon
Focus areas
AI, healthcare, medical imaging, hyperspectral imaging, neurodegenerative diseases, ophthalmology, diagnostics, early detection
Headquarters
Toronto, Ontario, Canada
Founded
2016
Employees
11–50
Status
Active · private